HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clegg, D. J. Articles by Seeley, R. J. Search for Related Content PubMed PubMed Citation Articles by Clegg, D. J. Articles by Seeley, R. J. Social Bookmarking                What's this?

Comparison of Central and Peripheral Administration of C75 on Food Intake, Body Weight, and Conditioned Taste Aversion

¹ Department of Psychiatry, University of Cincinnati, Cincinnati, Ohio
² Procter & Gamble Pharmaceuticals, Cincinnati, Ohio

Mice respond to fatty acid synthase (FAS) inhibitors by profoundly reducing their food intake and body weight. Evidence indicates that the central nervous system (CNS) may be the critical site of action; however, a peripheral contribution cannot be ruled out. We compared doses of the FAS inhibitor C75 in the CNS (third ventricle [i3vt]) and periphery (intraperitoneal [IP]) to reduce food intake and body weight in rats. Centrally, the threshold dose was 3 µg, whereas a dose of 10 mg/kg was required peripherally. Such data argue for FAS activity in the CNS as a potent target for the actions of C75. To control for nonspecific effects of FAS inhibition, we compared C75 administration in two models of illness, conditioned taste aversion and need-induced sodium appetite. Our results suggest the anorexia produced by IP C75 is accompanied by visceral illness, whereas the anorexia produced by i3vt is not. In addition, we placed animals in an indirect calorimeter after an IP injection of C75. We found that consistent with behavioral measures of visceral illness, peripheral C75 reduced heat expenditure and resulted in animals losing less weight than fasted control animals, suggesting that peripherally administered C75 has aversive properties. Understanding the mechanisms by which FAS inhibition in the CNS reduces food intake could lead to specific targets for the manipulation of energy balance and the treatment of obesity.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				K. Proulx, D. Cota, S. C. Woods, and R. J. Seeley Fatty Acid Synthase Inhibitors Modulate Energy Balance via Mammalian Target of Rapamycin Complex 1 Signaling in the Central Nervous System Diabetes, December 1, 2008; 57(12): 3231 - 3238. [Abstract] [Full Text] [PDF]

				S. Dridi, C. Ververken, F. B. Hillgartner, A. Lutgarde, E. Van der Gucht, L. Cnops, E. Decuypere, and J. Buyse FAS inhibitor cerulenin reduces food intake and melanocortin receptor gene expression without modulating the other (an)orexigenic neuropeptides in chickens Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R138 - R147. [Abstract] [Full Text] [PDF]

				S. Aja, S. Bi, S. B. Knipp, J. M. McFadden, G. V. Ronnett, F. P. Kuhajda, and T. H. Moran Intracerebroventricular C75 decreases meal frequency and reduces AgRP gene expression in rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R148 - R154. [Abstract] [Full Text] [PDF]

				M. Lopez, C. J. Lelliott, S. Tovar, W. Kimber, R. Gallego, S. Virtue, M. Blount, M. J. Vazquez, N. Finer, T. J. Powles, et al. Tamoxifen-Induced Anorexia Is Associated With Fatty Acid Synthase Inhibition in the Ventromedial Nucleus of the Hypothalamus and Accumulation of Malonyl-CoA. Diabetes, May 1, 2006; 55(5): 1327 - 1336. [Abstract] [Full Text] [PDF]

				S. Lu and M. C. Archer Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer Carcinogenesis, January 1, 2005; 26(1): 153 - 157. [Abstract] [Full Text] [PDF]

				G. N. Wade and J. E. Jones Neuroendocrinology of nutritional infertility Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1277 - R1296. [Abstract] [Full Text] [PDF]

				E.-K. Kim, I. Miller, S. Aja, L. E. Landree, M. Pinn, J. McFadden, F. P. Kuhajda, T. H. Moran, and G. V. Ronnett C75, a Fatty Acid Synthase Inhibitor, Reduces Food Intake via Hypothalamic AMP-activated Protein Kinase J. Biol. Chem., May 7, 2004; 279(19): 19970 - 19976. [Abstract] [Full Text] [PDF]

				L. E. Landree, A. L. Hanlon, D. W. Strong, G. Rumbaugh, I. M. Miller, J. N. Thupari, E. C. Connolly, R. L. Huganir, C. Richardson, L. A. Witters, et al. C75, a Fatty Acid Synthase Inhibitor, Modulates AMP-activated Protein Kinase to Alter Neuronal Energy Metabolism J. Biol. Chem., January 30, 2004; 279(5): 3817 - 3827. [Abstract] [Full Text] [PDF]

				K. A. Takahashi, J. L. Smart, H. Liu, and R. D. Cone The Anorexigenic Fatty Acid Synthase Inhibitor, C75, Is a Nonspecific Neuronal Activator Endocrinology, January 1, 2004; 145(1): 184 - 193. [Abstract] [Full Text] [PDF]

				Z. Hu, S. H. Cha, S. Chohnan, and M. D. Lane Hypothalamic malonyl-CoA as a mediator of feeding behavior PNAS, October 28, 2003; 100(22): 12624 - 12629. [Abstract] [Full Text] [PDF]

				S. Gao and M. D. Lane Effect of the anorectic fatty acid synthase inhibitor C75 on neuronal activity in the hypothalamus and brainstem PNAS, May 13, 2003; 100(10): 5628 - 5633. [Abstract] [Full Text] [PDF]